Literature DB >> 8035910

Favorable amphiphilicity of nimodipine facilitates its interactions with brain membranes.

L G Herbette1, P E Mason, K R Sweeney, M W Trumbore, R P Mason.   

Abstract

Nimodipine is a 1,4-dihydropyridine (DHP) calcium channel blocker which is used in the treatment of neurological deficits associated with subarachnoid hemorrhage. Small angle x-ray diffraction, differential scanning calorimetry, and equilibrium and kinetic binding techniques were used to study the interaction of nimodipine with bovine brain phosphatidylcholine (BBPC) membranes of varying cholesterol content. At concentrations (5 x 10(-10) M) near its Kd, the membrane partition coefficient of nimodipine was inversely related to the cholesterol to phospholipid (C:P) mole ratio in both model and native (rat synaptoneurosome) membranes. The nonspecific dissociation rate of nimodipine from BBPC was significantly slower at low C:P mole ratio (0.1:1) than at high C:P mole ratio (0.6:1). Calorimetric analysis showed that nimodipine decreased both the main phase transition temperature and cooperative unit size of melt for dimyristoyl phosphatidylcholine, dependent on membrane cholesterol content. Small angle x-ray diffraction analysis showed that nimodipine occupies a position in BBPC approx +/- 15 A from the center of the hydrocarbon core, near the hydrocarbon core/water interface. These data indicate that nimodipine is an amphiphilic molecule which rapidly washes out of and transports across membrane bilayers, facilitating its interactions with membranes and possibly its transport across the blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8035910     DOI: 10.1016/0028-3908(94)90015-9

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  4 in total

Review 1.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

2.  Effect of natural borneol on the pharmacokinetics and distribution of nimodipine in mice.

Authors:  Chun Wu; Qiongfeng Liao; Meicun Yao; Xinjun Xu; Yuting Zhou; Xueying Hou; Zhiyong Xie
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-05-15       Impact factor: 2.441

3.  Tetracaine-membrane interactions: effects of lipid composition and phase on drug partitioning, location, and ionization.

Authors:  Jingzhong Zhang; Theresa Hadlock; Alison Gent; Gary R Strichartz
Journal:  Biophys J       Date:  2007-03-09       Impact factor: 4.033

Review 4.  Nimodipine Pharmacokinetic Variability in Various Patient Populations.

Authors:  Sherif Hanafy Mahmoud; Xinqi Ji; Fadumo Ahmed Isse
Journal:  Drugs R D       Date:  2020-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.